Catalyst

Slingshot members are tracking this event:

Phase 2a interim data of Assembly Bio's (ASMB) ABI-H0731 in Hepatitis B virus (HBV) to be presented at EASL April 13, 2019.

Source Link:
https://investor.assemblybio.com/news-releases/news-release-details/assembly-biosciences-announces-multiple-abstracts-highlighting

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
ASMB Community voting in process
SIGN ME UP
I want to vote! LOG ME IN
Now!
Slingshot Insights Explained
JOIN FOR FREE TODAY
Catalyst Date
Occurred on:
Apr 13, 2019
Occurred Source:
https://investor.assemblybio.com/news-releases/news-release-details/assembly-biosciences-presents-interim-data-two-phase-2a-studies
Related Projects Image

  • Don’t see a project related to the catalyst you care about?

Related Keywords Hepatitis B, Hbv, Abi-h0731
About Us
Media Center
Connect with Us
© 2024 Slingshot Insights. All rights reserved.